SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-138290
Filing Date
2018-04-27
Accepted
2018-04-27 14:28:05
Documents
16
Period of Report
2018-04-27

Document Format Files

Seq Description Document Type Size
1 6-K d573546d6k.htm 6-K 13189
2 EX-99.1 d573546dex991.htm EX-99.1 460363
3 EX-99.2 d573546dex992.htm EX-99.2 34821
4 GRAPHIC g573546g0427152042187.jpg GRAPHIC 2293
5 GRAPHIC g573546g0427152044464.jpg GRAPHIC 735
6 GRAPHIC g573546g0427152045572.jpg GRAPHIC 734
7 GRAPHIC g573546g0427152046133.jpg GRAPHIC 735
8 GRAPHIC g573546g0427152046695.jpg GRAPHIC 740
9 GRAPHIC g573546g0427152047272.jpg GRAPHIC 745
10 GRAPHIC g573546g0427152047865.jpg GRAPHIC 749
11 GRAPHIC g573546g0427152048458.jpg GRAPHIC 737
12 GRAPHIC g573546page_21.jpg GRAPHIC 198082
13 GRAPHIC g573546page_22.jpg GRAPHIC 181219
14 GRAPHIC g573546page_23.jpg GRAPHIC 154366
15 GRAPHIC g573546page_24.jpg GRAPHIC 163934
16 GRAPHIC g573546page_25.jpg GRAPHIC 108303
  Complete submission text file 0001193125-18-138290.txt   1631213
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 18782969
SIC: 2834 Pharmaceutical Preparations